GECROL
Prophylaxis and treatment of transplant rejection in allograft recipients
GECROL 1 mg contains 1 mg tacrolimus Excipient with known effect: lactose 108.6 mg.
GECROL 5 mg contains 5 mg tacrolimus Excipient with known effect: lactose 104.6 mg.
GECROL is indicated in children and adults for the prophylaxis of transplant rejection in recipients of liver, kidney or heart allogeneic graft.
Treatment is used in case of allograft rejection resistant to treatment with other immunosuppressive medical products.
Medicinal product is subjected to medical prescription. The medicinal product is covered by public health insurance.